Skip to content

Taxes Paid at other companies

Theravance Biopharma logo
Theravance BiopharmaTBPH
-$351K-8,875%
Rigel Pharmaceuticals logo
Rigel PharmaceuticalsRIGL
$265.75K+221%
Opko Health logo
Opko HealthOPK
-$2.57M-225%
Innoviva, Inc. logo
Innoviva, Inc.INVA
$670K
NovoCure logo
NovoCureNVCR
-$3.88M-178%
Ligand Pharmaceuticals logo
Ligand PharmaceuticalsLGND
$774K+176%

Other financials

Income statement

See full
Revenue$22.5M+2.1%
Gross profit$21.3M+0.6%
Operating income-$9.4M-512%
Net income-$8.7M-422%
EPS (diluted)-$0.10

Balance sheet

See full
Cash & equivalents$37.5M+149%
Total debt$823.0K-48.1%
Total equity$101.3M+48.7%
Total assets$162.0M+24.8%

Cash flow

See full
Operating cash flow$3.2M+2,565%
CapEx$178.0K+45.9%
Free cash flow$3.0M+1,296%

Valuation

See full
Market cap$694.58M-4.7%
Enterprise value$657.9M-8.0%
P/S5.9×-1.3×

Profitability

See full
Gross margin95.1%-1.1pp
Operating margin-0.1%-10.4pp
Net margin6.3%+3.3pp
FCF margin2.6%

Returns & leverage

See full
Return on equity8.2%+4.2pp
Debt / equity0.0×
Current ratio4.6×+1.0×

Where this comes from

Reported directly by Gyre Therapeutics, Inc. in its filing.

Tagged under the XBRL concept us-gaap:IncomeTaxesPaidNet.

The official record: Gyre Therapeutics, Inc.’s 10-Q, filed May 8, 2026, on SEC EDGAR. View the filing →

Ask your AI about Gyre Therapeutics, Inc.'s taxes paid.

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI
Harbor at dusk
Claude

Questions, answered.

What is Gyre Therapeutics, Inc.'s taxes paid?
Gyre Therapeutics, Inc. (GYRE) reported taxes paid of $1.21M in Q1 2026.
How has Gyre Therapeutics, Inc.'s taxes paid changed year-over-year?
Gyre Therapeutics, Inc.'s taxes paid decreased by 63.9% year-over-year, from $3.36M to $1.21M.
What is the long-term trend for Gyre Therapeutics, Inc.'s taxes paid?
Over 3 years (2022 to 2025), Gyre Therapeutics, Inc.'s taxes paid has grown at a -3.8% compound annual growth rate (CAGR), from $6.31M to $5.62M.
What does taxes paid mean?
Actual cash paid to tax authorities for income taxes during the period — may differ from income tax expense due to timing.